Lithium: study card

Lithium — Mood stabilizer. Study the mechanism, listed uses and warnings from the US label on one sourced card.

Generic name
Lithium
Class
Mood stabilizer
Mechanism
Mechanism of action as a mood stabilizer is unknown.
Used for
Monotherapy for acute manic or mixed episodes of bipolar I disorder in patients aged 7 years and older; Maintenance monotherapy for bipolar I disorder in patients aged 7 years and older
Common side effects
Fine hand tremor; Polyuria; Mild thirst; Nausea
Boxed warning
Lithium toxicity is closely tied to serum levels and can occur near therapeutic concentrations; serum level testing must be available.
Warnings
Polyuria and hyponatremia raise toxicity risk; Lithium-induced chronic kidney disease; Thyroid disorders, hypercalcemia
Interactions
Diuretics, NSAIDs, RAS antagonists; Serotonergic agents; Antipsychotics

Brand questions use only name pairings verified against the linked product source. Unverified pairings are withheld from these questions; the other study content remains available.

Read the source label ↗

Label date: 20260831 · For learning, not clinical decisions. US label and brand information; always consult the current source.

Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.

Pronunciation

Lithium: LITH-ee-um

Pronunciation is shown for the US English generic name.

Body system

Psychiatry · 30 Drug cards

Boxed warnings on related cards

Other cards with a boxed warning in this body system (Psychiatry): Sertraline, Escitalopram, Bupropion, Fluoxetine, Trazodone, Amphetamine / Dextroamphetamine, Duloxetine, Alprazolam, Citalopram, Venlafaxine, Zolpidem, Methylphenidate (+14)